EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Evaluation of Vestibular Functions in a Case of Vestibular Migraine With Successful Treatment With Erenumab

Takaki Inui iD, Fumiharu Kimura, Kou Moriyama, Tatsuro Kuriyama, Takeo Shirai, Yusuke Ayani, Yuko Inaka, Masako Yuki, Shin-Ichi Haginomori iD, Ryo Kawata

Ear, Nose & Throat Journal · 2025

DOI: 10.1177/01455613231202200 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Ear, Nose & Throat Journal, 2025. Verfasst von Takaki Inui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology - Head & Neck Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan. Hauptthemen laut MEDLINE: Migraine Disorders, Antibodies, Monoclonal, Humanized, Calcitonin Gene-Related Peptide Receptor Antagonists, Meniere Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This is the first report of vestibular examinations before and after the successful treatment of vestibular migraine (VM), a common cause of recurrent vertigo, with calcitonin gene-related peptide (CGRP) receptor inhibitor. We evaluated a 42-year-old female with VM and concomitant probable Meniere’s disease, whose headache and dizziness have improved promptly with the administration of erenumab, a CGRP receptor inhibitor. The sensorineural hearing loss in pure-tone audiometry, dysfunctions shown in vestibular examinations (cervical and ocular vestibular evoked myogenic potentials), and mild endolymphatic hydrops shown in gadolinium-enhanced inner ear magnetic resonance imaging, all in the right ear, revealed no change compared with those observed before treatment. This case suggests that VM may be treated by blocking CGRP in the trigeminal ganglion, which suppresses the effects on the vestibular nucleus; herein, no effects were observed in the inner ear despite the clear amelioration of dizziness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersAntibodies, Monoclonal, HumanizedCalcitonin Gene-Related Peptide Receptor AntagonistsMeniere DiseaseHumansFemaleAdultVertigoTreatment OutcomeMagnetic Resonance ImagingVestibular Function TestsVestibular Evoked Myogenic PotentialsDizzinessHearing Loss, SensorineuralAudiometry, Pure-Tone

Stichwörter der Autor:innen

calcitonin gene-related peptide receptor inhibitordizzinesspathophysiologyvestibular examinationsvestibular migraine

Substanzen

Antibodies, Monoclonal, HumanizedCalcitonin Gene-Related Peptide Receptor Antagonistserenumab

Autor:innen und Institutionen

  • Department of Otorhinolaryngology - Head & Neck Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Department of Neurology, Osaka Medical and Pharmaceutical University Mishima-minami Hospital, Takatsuki, Osaka, Japan.
  • Department of Radiology, Hokusetsu General Hospital, Takatsuki, Japan.

ORCID-Profile: Takaki Inui, Shin-Ichi Haginomori

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Inui, T., Kimura, F., Moriyama, K., Kuriyama, T., Shirai, T., Ayani, Y., Inaka, Y., Yuki, M., Haginomori, S. I., & Kawata, R. (2025). Evaluation of Vestibular Functions in a Case of Vestibular Migraine With Successful Treatment With Erenumab. Ear, Nose & Throat Journal. https://doi.org/10.1177/01455613231202200

Vancouver

Inui T, Kimura F, Moriyama K, Kuriyama T, Shirai T, Ayani Y, et al. Evaluation of Vestibular Functions in a Case of Vestibular Migraine With Successful Treatment With Erenumab. Ear, Nose & Throat Journal. 2025. doi:10.1177/01455613231202200

BibTeX
@article{Inui2025,
  author = {Inui, Takaki and Kimura, Fumiharu and Moriyama, Kou and Kuriyama, Tatsuro and Shirai, Takeo and Ayani, Yusuke and Inaka, Yuko and Yuki, Masako and Haginomori, Shin-Ichi and Kawata, Ryo},
  title = {Evaluation of Vestibular Functions in a Case of Vestibular Migraine With Successful Treatment With Erenumab},
  journal = {Ear, Nose & Throat Journal},
  year = {2025},
  doi = {10.1177/01455613231202200}
}
Kostenlos starten →